Close Menu

NEW YORK (GenomeWeb) – A steep decline in the broader biotechnology space dragged down shares of life science omics tools and molecular diagnostic firms in September. 

Compared to August, the GenomeWeb Index fell nearly 8 percent last month, following a similar nearly 8 percent drop month over month in August. Of the 31 companies comprising the index, just two, NanoString Technologies and Hologic, registered month-over-moth gains in September.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.